Prescribing and dispensing epinephrine auto-injectors: What you need to know
Pharmacists in community-based practice.
Universal program number: 0401-0000-17-005-H01-P
CE Broker tracking number: 20-614096
Activity type: Knowledge-based
To provide the community pharmacist with an overview of anaphylaxis, available epinephrine emergency treatment options and the requirements for prescribing and dispensing auto-injectors.
As the value of pharmacists in meeting public health concerns continues to be acknowledged, many boards of pharmacy and other entities are taking action to expand the practice of pharmacy and leverage the multiple access points that community pharmacies provide. This value is increased when solutions for critical products and services are needed. Pharmacists are well-positioned in the community to serve as accessible healthcare professionals in providing access to emergency epinephrine. In July 2016, Senate Bill 1322a permitted Idaho to become the first state to allow pharmacists to prescribe epinephrine auto-injectors to individual patients and authorized entities.1 With the passage of the Idaho legislation, other states are likely to follow suit. This education provides guidance for pharmacists to educate patients on signs and symptoms of anaphylaxis, and to confidently prescribe an epinephrine auto-injector, where allowed by state law, or recommend a patient’s provider write a prescription.
Upon completion of this program, the pharmacist should be able to:
- Describe the immunologic mechanism of anaphylaxis.
- List the main types of anaphylaxis reaction.
- Recall signs and symptoms of anaphylaxis.
- Outline key counseling points for epinephrine auto-injectors.
- List requirements for pharmacist prescribing of epinephrine auto-injectors.
To obtain credit:
To complete the program and receive CPE credit, view all lesson content and complete the learning assessment by submitting answers online. A minimum test score of 70% is needed to obtain credit. After successfully completing the learning assessment, participants must complete a program evaluation and claim the available CPE credit. Participants also must verify personal information required by CPE monitor and/or CE Broker (for Florida license holders) prior to submitting CPE credit claims. Official statements of credit are available only through CPE Monitor located at NABP.net.
If you have a question, visit our Frequently Asked Questions page.
All other customer service questions should be directed to DRSNCE@lf1925.com.
Drug Store News is accredited by the Accreditation Council for Pharmacy Education (ACPE) as a provider of continuing pharmacy education. This CPE activity is approved for pharmacists and is worth 1.0 contact hours (0.1 CEUs). The activity is available for CE credit through July 11, 2020.
Sunny Lu, PharmD, PGY1 community pharmacy resident at Safeway NorCal and UCSF School of Pharmacy; Rebecca Strauss, PharmD, corporate pharmacy trainer and residency director at Albertsons Companies; Jenny Hong, PharmD, clinical pharmacist, Albertsons Companies; and Jeffrey Hamper, PharmD, BCACP, manager, academic relations at Albertsons Companies
Sunny Lu, Rebecca Strauss, Jenny Hong, Jeffrey Hamper and the DSN editorial and continuing education staff do not have any actual or potential conflicts of interest in relation to this lesson.
- 1.00 Pharmacist